TerrAscend (TSNDF) Cash & Equivalents Growth (3y) (2024 - 2026)

TerrAscend (TSNDF) Cash & Equivalents Growth (3y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash & Equiv. Growth (3y) (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-	21.81%
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn	11.05%
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn	-4.92%
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	7.80%
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn	19.10%
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn	12.11%
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn	27.55%
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn	13.03%
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	32.82%
10	TerrAscend	197.99 Mn	155.88 Mn	36.25 Mn	13.27%

Download Data